News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioMidwest
Baxter International, Inc. to Present at the 28th Annual J.P. Morgan Healthcare Conference
January 7, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010 at 1:30 p.m. (PST) or 4:30 p.m. (EST).
Twitter
LinkedIn
Facebook
Email
Print
Events
Baxter International, Inc.
MORE ON THIS TOPIC
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
April 17, 2026
·
5 min read
·
Nick Paul Taylor
Rare diseases
Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor
April 2, 2026
·
6 min read
·
Heather McKenzie
Immunology and inflammation
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
March 31, 2026
·
4 min read
·
Tristan Manalac